The global Cancer Biomarkers Market is poised for remarkable growth over the coming decade as healthcare systems worldwide continue to prioritize early cancer detection, precision medicine, and targeted therapeutic interventions. Valued at US$ 27.8 billion in 2025, the market is projected to reach more than US$ 100.9 billion by 2036, expanding at a robust compound annual...